Menu
GeneBe

rs148985828

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_002700.3(POU4F3):c.513C>A(p.Ser171Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,610,704 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S171S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00016 ( 1 hom. )

Consequence

POU4F3
NM_002700.3 missense

Scores

2
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 0.300
Variant links:
Genes affected
POU4F3 (HGNC:9220): (POU class 4 homeobox 3) This gene encodes a member of the POU-domain family of transcription factors. POU-domain proteins have been observed to play important roles in control of cell identity in several systems. This protein is found in the retina and may play a role in determining or maintaining the identities of a small subset of visual system neurons. Defects in this gene are the cause of non-syndromic sensorineural deafness autosomal dominant type 15. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10919702).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000118 (18/152218) while in subpopulation NFE AF= 0.00022 (15/68040). AF 95% confidence interval is 0.000135. There are 0 homozygotes in gnomad4. There are 8 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd at 18 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POU4F3NM_002700.3 linkuse as main transcriptc.513C>A p.Ser171Arg missense_variant 2/2 ENST00000646991.2
LOC127814297NM_001414499.1 linkuse as main transcriptc.*382C>A 3_prime_UTR_variant 20/20

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POU4F3ENST00000646991.2 linkuse as main transcriptc.513C>A p.Ser171Arg missense_variant 2/2 NM_002700.3 P1
ENST00000515598.1 linkuse as main transcriptn.404-32664G>T intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.000118
AC:
18
AN:
152218
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000105
AC:
26
AN:
247758
Hom.:
0
AF XY:
0.000126
AC XY:
17
AN XY:
134454
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000221
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000164
AC:
239
AN:
1458486
Hom.:
1
Cov.:
31
AF XY:
0.000174
AC XY:
126
AN XY:
725754
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.0000199
Gnomad4 NFE exome
AF:
0.000201
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.000118
AC:
18
AN:
152218
Hom.:
0
Cov.:
33
AF XY:
0.000108
AC XY:
8
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.000220
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000245
Hom.:
0
Bravo
AF:
0.000102
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000124
AC:
15
EpiCase
AF:
0.000382
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 04, 2016The p.Ser171Arg variant in POU4F3 has not been previously reported in individual s with hearing loss, but has been identified in 13/65634 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s148985828). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational predic tion tools and conservation analyses do not provide strong support for or agains t an impact to the protein. In summary, the clinical significance of this varian t is uncertain. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 21, 2023The c.513C>A (p.S171R) alteration is located in exon 2 (coding exon 2) of the POU4F3 gene. This alteration results from a C to A substitution at nucleotide position 513, causing the serine (S) at amino acid position 171 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal dominant nonsyndromic hearing loss 15 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJul 26, 2021- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeSep 11, 2023This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 171 of the POU4F3 protein (p.Ser171Arg). This variant is present in population databases (rs148985828, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with POU4F3-related conditions. ClinVar contains an entry for this variant (Variation ID: 504672). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POU4F3 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.31
Cadd
Benign
17
Dann
Benign
0.93
DEOGEN2
Benign
0.19
T;T
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.26
FATHMM_MKL
Benign
0.73
D
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
0.34
N;N
MutationTaster
Benign
0.66
D
PrimateAI
Uncertain
0.60
T
Polyphen
0.50
P;P
Vest4
0.30
MutPred
0.19
Loss of glycosylation at S171 (P = 0.0077);Loss of glycosylation at S171 (P = 0.0077);
MVP
0.45
MPC
0.53
ClinPred
0.046
T
GERP RS
2.8
Varity_R
0.13
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148985828; hg19: chr5-145719503; API